**To the Editor:** Multidrug resistance in bacteria isolated from animals is an emerging phenomenon, mirroring what is happening among humans. During the past decade, expanded-spectrum β-lactamases in *Enterobacteriaceae* from humans ([@R1]) and animals ([@R2]) worldwide have been reported. Among humans, as a consequence of this high rate, use of carbepenems is increasing selection pressure; carbapenem-resistant gram-negative organisms are increasingly reported, including carbapenemase-producing *Enterobacteriaceae* and *Acinetobacter* spp ([@R3]).

The most commonly acquired carbapenemases identified in *Acinetobacter* spp. correspond to carbapenem-hydrolyzing class D β-lactamases ([@R3]). In particular, the worldwide spread of OXA-23--producing *A. baumannii* is considered a serious threat; those strains are frequently involved in nosocomial outbreaks for which therapeutic options are extremely limited ([@R3]*,*[@R4]). Our study objective was to evaluate the possible occurrence of carbapenemase-producing gram-negative bacteria in dairy cattle in France.

In August 2010, at a dairy farm 30 km from Paris, France, rectal swabs were collected from 50 cows. Samples were precultured in buffered peptone water and incubated for 18 h at 37°C. Cultures were inoculated by streaking 100 μL of the suspensions onto Drigalski agar plates (bioMérieux, Balmes-les-Grottes, France) containing 1 μg/mL of imipenem to select for carbapenem-resistant gram-negative isolates. Of the 50 samples, 9 produced growth on imipenem-containing plates. All colonies tested (10 colonies/sample) by using the API 20 NE (bioMérieux) system were first identified as *A. lwoffii*. Molecular techniques based on sequencing of the *gyrA*, *gyrB*, and *rpoB* genes ([@R5]) enabled more precise identification and indicated that all isolates belonged to the *Acinetobacter* genomospecies (DNA group) 15TU, which is known to be phylogenetically related to *A. lwoffii* and which has been reportedly isolated from sewage, freshwater aquaculture habitats, trout intestines, and frozen shrimp ([@R6]).

One colony per sample was retained for further investigation (isolates BY1 to BY9). Susceptibility testing and MIC determinations were performed by disk-diffusion assay (Sanofi-Diagnostic Pasteur, Marnes-la-Coquette, France) and Etest (AB bioMérieux, Solna, Sweden) ([Table](#T1){ref-type="table"}). All isolates except 1 were resistant to penicillins, combinations of penicillins and β-lactamase inhibitors, and carbapenems but susceptible to cefotaxime and of reduced susceptibility to ceftazidime. Isolate BY1 showed higher MICs for carbapenems ([Table](#T1){ref-type="table"}). In addition, all isolates were resistant to tetracycline, kanamycin, and fosfomycin and remained susceptible to fluoroquinolones, chloramphenicol, gentamicin, amikacin, tobramycin, and sulfonamides. Susceptibility profiles of 3 *Acinetobacter* genomospecies 15TU reference strains showed that they were fully susceptible to penicillins, carbapenems, tetracycline, and kanamycin.

###### Antimicrobial drug MICs for *Acinetobacter* genomospecies 15TU isolates from cows and reference strains, France, August 2010

  Drug class                     MIC, μg/mL                             
  ------------------------------ ------------ -------------- -- ------- -------
  Penicillins and combinations                                          
  Amoxicillin                    \>256        128--256          4       4
  Amoxicillin + CLA              \>256        128--256          4       4
  Cephalosporins                                                        
  Cefoxitin                      32           16--32            16      16
  Cefotaxime                     32           16--32            8       6
  Ceftazidime                    32           16--32            16      16
  Cefepime                       16           4--16             4       4
  Monobactam (aztreonam)         64           32                32      16
  Carbapenems                                                           
  Meropenem                      16           2--4              0.5     0.5
  Imipenem                       \>32         4--6              0.25    0.25
  Doripenem                      8            2--4              0.5     0.5
  Cyclines                                                              
  Tetracycline                   \>256        \>256             0.5     0.5
  Tigecycline                    0.064        0.047--0.064      0.047   0.125
  Quinolones (ciprofloxacin)     0.5          0.5               0.25    0.25
  Aminoglycosides                                                       
  Gentamicin                     0.5          0.25--0.5         0.25    0.25
  Kanamycin                      \>256        \>256             0.5     0.5
  Sulfonamides                   4            4                 4       \>256

\*CLA, clavulanic acid (4 μg/mL).

Clonal diversity between the isolates was assessed by pulsed-field gel electrophoresis ([@R5]), which showed 6 distinct genotypes. Isolate BY1 corresponded to a single clone (data not shown), which indicated that the occurrence of *Acinetobacter* genomospecies 15TU strains among these animals was not the result of dissemination of a single clone.

PCR detection and sequencing of genes that encode carbapenem-hydrolyzing class D β-lactamases ([@R5]) showed that the 9 *Acinetobacter* genomospecies 15TU isolates harbored a *bla*~OXA-23~ gene, whereas the 3 reference strains remained negative. Sequencing confirmed that all isolates expressed β-lactamase OXA-23, which is known to be widespread in *A. baumannii*.

Mating-out assays and plasmid electroporation assays were performed by using *bla*~OXA-23~--positive *Acinetobacter* spp. isolates as donors and rifampin-resistant *A. baumannii* BM4547 isolates as a recipient strain ([@R5]); however, these assays were unsuccessful. Plasmid DNA analysis ([@R5]) gave uninterpretable results, with DNA degradations.

The genetic structures surrounding the *bla*~OXA-23~ gene were investigated by PCR mapping ([@R7]), which identified transposon Tn*2008* in isolate BY2 only. Tn*2008* is a major vehicle for the spread of the *bla*~OXA-23~ gene in *A. baumannii* in the People's Republic of China ([@R8]) and the United States ([@R9]). In the other isolates, the IS*Aba1* element of Tn*2008* had been truncated by a novel insertion sequence termed IS*Acsp2* ([www-is.biotoul.fr](http://www-is.biotoul.fr)).

The dairy farmer indicated that most animals from which OXA-23 producers had been identified had received antimicrobial drugs in the previous weeks. Although 1 animal had received amoxicillin-clavulanate, most of the others had been given oxytetracycline and neomycin to treat mastitis.

β-lactamase OXA-23 is a common source of carbapenem resistance in *A. baumannii (*[@R5]*)*. Infections with multidrug-resistant OXA-23--producing *A. baumannii* or *A. junii* have been reported from hospitals but not from the community. Our study showed that OXA-23--producers in particular, and carbapenemase producers in general, may be isolated from animals. Among the hypotheses that could explain the selection of this carbapenemase, use of penicillins or penicillin--β-lactamase inhibitor combinations could create selective pressure for β-lactamases because OXA-23 does confer, in addition to decreased susceptibility to carbapenems, a high level of resistance to those compounds. We have previously shown that *A. radioresistens*, an environmental species, was the progenitor of the *bla*~OXA-23~ gene ([@R10]). Studies are needed to determine to what extent and at which locations *Acinetobacter* genomospecies 15TU and *A. radioresistens* might co-reside and therefore where the *bla*~OXA-23~ gene exchange might have occurred.
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